FDA’s Orange Book Dispute Resolution Process May Grow Teeth With FTC Patent Listing Challenges

Dispute book
FTC invokes new use of FDA process to challenge Orange Book patent listings • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products